Angioplasty for the Treatment of Visceral Ischemia

Hallisey, Michael J.; Deschaine, Jason; Illescas, Fernando F.; Sussman, Steven K.; Vine, Hugh S.; Ohki, Stephen K.; Straub, J. John

doi:10.1016/s1051-0443(95)71186-1

Cited by 85 publications

(26 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The long-term clinical success of our study (88% Å mean follow-up at 27 months) is similar to that of other investigators (63-100%, mean Å 77% for follow-up periods of 3-60 months) [3][4][5][6][7][8][9][10][11][12]. The primary longterm clinical success is equal to that of surgery (50-100%, mean Å 84% for follow-up periods of 24-69 months) [2,[15][16][17][18][19][20][21][22][23][24][25].…”

Section: Discussionsupporting

confidence: 88%

“…Our results on PTA of visceral arteries coincide with those of other investigators (Table 3) where the technical success rate in relation to the number of patients is 81% (range Å 25-100%), the technical success rate in relation to the number of lesions is 72% (range Å 30-89%), the initial clinical success rate is 96% (range Å 80-100%), the periprocedural mortality rate is 2% (range Å 0-13%), and the morbidity rate is 10% (range Å 0-25%) [2][3][4][5][6][7][8][9][10][11]. Such results compared with those carried out by surgery are encouraging.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Percutaneous transluminal angioplasty in the treatment of chronic mesenteric ischemia: results and 3 years of follow-up in 23 patients

et al. 1998

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionmentioning

confidence: 99%

Percutaneous transluminal angioplasty in the treatment of chronic mesenteric ischemia: results and 3 years of follow-up in 23 patients

et al. 1998

View full text Add to dashboard Cite

show abstract

“…4, 5), therefore, has become a more acceptable approach for stenotic or occlusive lesions. The ideal morphology for endovascular treatment is a short stenosis (less than 2 cm) that is located near the ostia of the main splanchnic branches as demonstrated by initial technical success rates of 95% in ostial lesions and 78% in nonostial lesions [25,26]. Regarding patency of the endovascular therapy, a study following up 23 consecutive patients showed overall clinical success after 27 months in 88%.…”

Section: Endovascular Therapymentioning

confidence: 99%

Chronic Mesenteric Ischemia – Surgical and Interventional Options in Therapy

et al. 2006

View full text Add to dashboard Cite

Chronic mesenteric ischemia (CMI) is an unusual but important cause of abdominal pain accounting for 5-8% of all intestinal ischemic events. Most commonly it is caused by atherosclerotic occlusions or severe stenosis. Symptoms occur when at least two of the three main splanchnic vessels are affected. The course is frequently asymptomatic, resulting from an extensive collateralization. Intestinal angina combined with weight loss and sitophobia are typical clinical features. Therapeutic options are conventional surgical therapy with thrombendarterectomy or bypass as well as percutaneous angioplasty with or without stenting. In symptomatic disease immediate therapy is essential because the natural course is life-threatening. Invasive treatment of asymptomatic but significant CMI has to be seriously considered as it developed into symptomatic disease with a high possibility.

show abstract

“…However, we feel that embolization should be primarily attempted in patients with a nonruptured aneurysm when the vascular anatomy is suitable for selective catheterization because an arterial ligation or an aneurysm resection are not always feasible, and a major operation (i.e., a partial pancreatectomy) might be necessary [3,4].…”

mentioning

confidence: 99%

“…Regarding unruptured aneurysms, recanalization of the celiac axis may decompress the collaterals and cause the aneurysm to disappear [2]. Thus, percutaneous balloon angioplasty [3,4] or stent placement [5,6] may be a preventive measure that should be tried before more invasive surgical procedures, if treatment is considered warranted in these patients and as long as there are no definite signs of a median arcuate ligament syndrome.…”

mentioning

confidence: 99%